Literature DB >> 1384825

Effect of aprotinin on metastasis of Lewis lung tumor in mice.

S Uetsuji1, M Yamamura, S Takai, K Hioki, M Yamamoto.   

Abstract

Kallikrein activity in human stomach tissue was measured and found to be about threefold higher in cancer tissue than in normal tissue. To clarify the physiological role of this tissue kallikrein, we investigated its effects on the spontaneous metastasis and tumor growth of Lewis tumors (3LL). Antiprotease, aprotinin, and gabexate mesilate (FOY) inhibited spontaneous metastasis but did not inhibit tumor growth, while tissue kallikrein and plasmin enhanced the spontaneous metastasis of 3LL. The results suggest that the inhibitory effects of aprotinin and FOY on metastasis are not only due to an inhibition of tumor cells released by tissue kallikrein, but that tissue kallikrein, a protease, also participates in metastasis. We thus conclude that aprotinin or FOY should be administered either before or immediately after operation to inhibit spontaneous metastasis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1384825     DOI: 10.1007/bf00308795

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  13 in total

1.  [Administration of fibrinolysis activators and antifibrinolysin and the hematogenic spread of Walker carcinosarcoma metastases].

Authors:  P CAGLIANI; V MARINO; M SFORZA
Journal:  Biol Lat       Date:  1962 Apr-Jun

2.  EFFECT OF INHIBITORS OF FIBRINOLYTIC ENZYMES ON DEVELOPMENT OF PULMONARY METASTASES.

Authors:  E E CLIFFTON; D AGOSTINO
Journal:  J Natl Cancer Inst       Date:  1964-11       Impact factor: 13.506

3.  New method for estimation of various deaminases by direct colorimetric determination of ammonia.

Authors:  S Fujii; H Okuda
Journal:  Tokushima J Exp Med       Date:  1975-09

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  Purification and properties of a neutral protease from rat liver chromatin.

Authors:  M T Chong; W T Garrard; J Bonner
Journal:  Biochemistry       Date:  1974-12-03       Impact factor: 3.162

6.  Colon kallikrein, its relation to the plasma enzyme.

Authors:  T Seki; T Nakajima; E G Erdös
Journal:  Biochem Pharmacol       Date:  1972-05-01       Impact factor: 5.858

7.  [On a new cathepsin. Purification from bovine spleen, properties, as well as comparison with cathepsin B].

Authors:  K Otto
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1967-11

8.  Rat submandibular gland kallikreins: purification and cellular localization.

Authors:  P Brandtzaeg; K M Gautvik; K Nustad; J V Pierce
Journal:  Br J Pharmacol       Date:  1976-02       Impact factor: 8.739

9.  Characterization and purification of a kallikrein from human pancreatic juice and immunological comparison with other kallikreins.

Authors:  M Amouric; C Figarella
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1979-03

10.  Analysis of aprotinin-induced enhancement of metastasis of Lewis lung tumors in mice.

Authors:  G A Turner; L Weiss
Journal:  Cancer Res       Date:  1981-07       Impact factor: 12.701

View more
  3 in total

1.  Upregulation of tissue kallikrein, kinin B1 receptor, and kinin B2 receptor in mast and giant cells infiltrating oesophageal squamous cell carcinoma.

Authors:  Z Dlamini; K D Bhoola
Journal:  J Clin Pathol       Date:  2005-09       Impact factor: 3.411

2.  Effect of anti-fibrinolytic therapy on experimental melanoma metastasis.

Authors:  Jennifer M Kirstein; Kevin C Graham; Lisa T Mackenzie; Danielle E Johnston; Leslie J Martin; Alan B Tuck; Ian C MacDonald; Ann F Chambers
Journal:  Clin Exp Metastasis       Date:  2008-12-12       Impact factor: 5.150

3.  Proteinase inhibitors reduce basement membrane degradation by human breast cancer cell lines.

Authors:  P S Stonelake; C E Jones; J P Neoptolemos; P R Baker
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.